封面
市場調查報告書
商品編碼
1433610

合法大麻市場規模、佔有率和趨勢分析報告:2024-2030 年按應用、產品類型、地區和細分市場進行的預測

Legal Marijuana Market Size, Share & Trends Analysis Report By Application (Medical, Adult Use), By Product Type (Flower, Oils and Tinctures), By Region, And Segment Forecasts, 2024 - 2030

出版日期: | 出版商: Grand View Research | 英文 125 Pages | 商品交期: 2-10個工作天內

價格

合法大麻市場的成長與趨勢:

Grand View Research, Inc. 的一項新研究顯示,到 2030 年,全球合法大麻市場預計將達到 1,022.4 億美元。

預計2024年至2030年該市場將以25.7%的複合年成長率擴張。醫療和成人使用/娛樂大麻合法化率的提高、這些產品擴大用於治療慢性疾病以及新產品推出數量的增加是市場成長的主要驅動力。例如,2023 年 3 月,草藥補充品製造商 Irwin Naturals Inc. 在加拿大推出了新產品 CBD 25 毫克軟膠囊。該產品透過星籽醫藥醫療集團平台銷往全國。

2022 年 4 月,娛樂和醫用大麻將在新澤西州合法化,並可在 13 個設施中出售。此舉使新澤西州成為美國 18 個嗜好大麻合法的美國之一。由於大麻的廣泛接受和高需求,市場正在成長。自合法化以來,大麻在醫療中的使用增加,導致大麻非法交易減少。根據紐約大學的一項研究,50 至 64 歲人群吸食大麻的比例在過去十年中加倍,目前為 9.0%。

此外,合法大麻的價格低於醫用大麻,合法化後將對大麻產品徵稅。因此,種植者將重點放在免稅地區種植。例如,在紐約,大麻種植者集中在部落地區,以免除政府課稅。預計這將降低該州種植大麻的整體成本,並使種植者能夠以較低的價格出售大麻。大麻價格下降預計將進一步提高大麻在市場上的普及。

合法大麻市場報告亮點

  • 從應用來看,由於醫療保健專業人員和患者對藥用大麻的需求很高,醫療產業在 2023 年佔據了最大的銷售佔有率,達到 79.1%。
  • 按產品類型分類,油和酊劑在 2023 年佔據最大的市場佔有率,因為與其他產品相比,鮮花價格低廉且易於獲取。
  • 2023年,北美地區佔總市場銷售佔有率的76.0%。這是因為北美擁有龐大的消費群,而北美是最早將大麻用於醫療和娛樂目的合法化的地區之一。

目錄

第1章 合法大麻市場:調查方法與範圍

第2章合法大麻市場:執行摘要

  • 市場展望
  • 分部展望
  • 競爭考察

第3章 合法大麻市場:變數、趨勢、範圍

  • 市場體系展望
  • 市場動態
  • 合法大麻市場分析工具

第4章 合法大麻市場:使用量估計與趨勢分析

  • 2023年及2030年應用市場佔有率
  • 細分儀表板
  • 按用途分類的全球合法大麻市場前景
  • 2018年至2030年市場規模、預測與趨勢分析

第5章 合法大麻市場:產品類型估算與趨勢分析

  • 2023 年及 2030 年產品類型市場佔有率
  • 細分儀表板
  • 按產品類型分類的全球合法大麻市場展望
  • 2018年至2030年市場規模、預測與趨勢分析

第6章 合法大麻市場:區域估計與趨勢分析

  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概述
  • 2018-2030年市場規模及預測趨勢分析
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 荷蘭
    • 義大利
    • 西班牙
    • 克羅埃西亞
    • 波蘭
    • 捷克共和國
    • 瑞士
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 泰國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 哥倫比亞
    • 哥倫比亞
  • 中東/非洲
    • 南非
    • 伊薩雷爾

第7章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商形勢
    • Canopy Growth Corporation
    • AURORA CANNABIS INC.
    • Tilray Brands Inc.(Aphria, Inc.)
    • ABcann Medicinals, Inc.(VIVO Cannabis Inc.)
    • The Cronos Group
    • MARICANN INC.
    • Organigram Holdings Inc.
    • Lexaria Bioscience
    • GW Pharmaceuticals(Jazz Pharmaceuticals, Inc.)
    • Tikun Olam
    • United Cannabis Corporation
Product Code: GVR-2-68038-152-8

Legal Marijuana Market Growth & Trends:

The global legal marijuana market size is expected to reach USD 102.24 billion by 2030, according to a new study by Grand View Research, Inc. The market is expected to expand at a CAGR of 25.7% from 2024 to 2030. Increase in rate of legalization of marijuana for medicinal and adult-use/recreational marijuana, growing adoption of these products for the treatment of chronic ailments and rise in a number of new product launches are the primary factors responsible for the growth of the market. For instance, in March 2023, Irwin Naturals Inc., a herbal supplement formulator, introduced company's' new CBD 25mg Softgels in Canada. It is available through the Starseed Medicinal Medical Group platform across the nation.

In April 2022, New Jersey legalized recreational and medical marijuana, and it is being sold at 13 facilities. This move has made New Jersey one of the 18 states in the United States where recreational marijuana is legal. The market is experiencing growth due to the widespread acceptance of cannabis and its high demand. Since its legalization, the use of marijuana in medical treatments has increased, leading to a decrease in the illegal trade of cannabis. According to a study conducted by New York University, the usage of cannabis among individuals aged 50-64 has doubled in the last decade and has now reached 9.0%.

Moreover, price of legal marijuana is lower than medical marijuana, and taxes would be levied on marijuana products after its legalization. Therefore, cultivators are focusing on cultivating marijuana in areas that are exempt from taxes. For instance, in New York, marijuana cultivators are focusing on tribal regions to get exempted from the taxes levied by the government. This is expected to lower the overall cost of cultivation of marijuana in the state, and cultivators can sell marijuana at lower prices. Lower prices of marijuana are further anticipated to boost the adoption of marijuana in the market.

Legal Marijuana Market Report Highlights:

  • By application, medical segment accounted for the largest revenue share of 79.1% in 2023 owing to the high demand among healthcare practitioners and patients for medicinal marijuana.
  • By product type, oil and tinctures held the largest market share in 2023 owing to low price and ease of accessibility of flowers compared to other products.
  • In 2023, North America dominated the overall market with a revenue share of 76.0% owing to its large consumer base, North America was among the first regions to legalize the use of medical and recreational cannabis.

Table of Contents

Chapter 1. Legal Marijuana Market: Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Application
    • 1.2.2. Product Type
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Legal Marijuana Market: Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Application outlook
    • 2.2.2. Product type outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Legal Marijuana Market: Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing adoption of medical marijuana for treatment of chronic diseases
      • 3.2.1.2. Growing legalization of medical marijuana in various countries
      • 3.2.1.3. Elimination of black market through legalization of medical marijuana
      • 3.2.1.4. Impending legalization of marijuana for recreational/adult use
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Lower market access of marijuana due to absence of legalization programs in several Asian and African countries
      • 3.2.2.2. Legalization of medical marijuana only for selected indications
      • 3.2.2.3. Supply shortage of medical marijuana in various countries
  • 3.3. Legal Marijuana Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Legal Marijuana Market: Application Estimates & Trend Analysis

  • 4.1. Application Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Legal Marijuana Market by Application Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Medical
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.2. Cancer
      • 4.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.3. Chronic Pain
      • 4.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.4. Depression and Anxiety
      • 4.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.5. Arthritis
      • 4.4.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.6. Diabetes
      • 4.4.1.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.7. Glaucoma
      • 4.4.1.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.8. Migraines
      • 4.4.1.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.9. Epilepsy
      • 4.4.1.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.10. Multiple Sclerosis
      • 4.4.1.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.11. AIDS
      • 4.4.1.11.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.12. Amyotrophic Lateral Sclerosis
      • 4.4.1.12.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.13. Alzheimer's
      • 4.4.1.13.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.14. Post-Traumatic Stress Disorder (PTSD)
      • 4.4.1.14.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.15. Parkinson's
      • 4.4.1.15.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.16. Tourette's
      • 4.4.1.16.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.17. Others
      • 4.4.1.17.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Adult Use
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Legal Marijuana Market: Product Type Estimates & Trend Analysis

  • 5.1. Product Type Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Legal Marijuana Market by Product Type Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Flower
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Oil and tinctures
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Legal Marijuana Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2023 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. Netherlands
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/ reimbursement structure
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework/ reimbursement structure
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.6. Croatia
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework/ reimbursement structure
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.7. Poland
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Regulatory framework/ reimbursement structure
      • 6.6.7.3. Competitive scenario
      • 6.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.8. Czech Republic
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Regulatory framework/ reimbursement structure
      • 6.6.8.3. Competitive scenario
      • 6.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.9. Switzerland
      • 6.6.9.1. Key country dynamics
      • 6.6.9.2. Regulatory framework/ reimbursement structure
      • 6.6.9.3. Competitive scenario
      • 6.6.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.5. New Zealand
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/ reimbursement structure
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Regulatory framework/ reimbursement structure
      • 6.7.6.3. Competitive scenario
      • 6.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework/ reimbursement structure
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.2. Mexico
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework/ reimbursement structure
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.3. Colombia
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Regulatory framework/ reimbursement structure
      • 6.8.3.3. Competitive scenario
      • 6.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.4. Colombia
      • 6.8.4.1. Key country dynamics
      • 6.8.4.2. Regulatory framework/ reimbursement structure
      • 6.8.4.3. Competitive scenario
      • 6.8.4.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Regulatory framework/ reimbursement structure
      • 6.9.1.3. Competitive scenario
      • 6.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.2. Isarel
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Regulatory framework/ reimbursement structure
      • 6.9.2.3. Competitive scenario
      • 6.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
    • 7.3.4. Canopy Growth Corporation
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. AURORA CANNABIS INC.
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Tilray Brands Inc. (Aphria, Inc.)
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. ABcann Medicinals, Inc. (VIVO Cannabis Inc.)
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. The Cronos Group
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. MARICANN INC.
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Organigram Holdings Inc.
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Lexaria Bioscience
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. GW Pharmaceuticals (Jazz Pharmaceuticals, Inc.)
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. Tikun Olam
      • 7.3.13.1. Company overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. Product benchmarking
      • 7.3.13.4. Strategic initiatives
    • 7.3.14. United Cannabis Corporation
      • 7.3.14.1. Company overview
      • 7.3.14.2. Financial performance
      • 7.3.14.3. Product benchmarking
      • 7.3.14.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America legal marijuana market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 4 North America legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 5 U.S. legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 6 U.S. legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 7 Canada legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 8 Canada legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 9 Europe legal marijuana market, by region, 2018 - 2030 (USD Million)
  • Table 10 Europe legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 11 Europe legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 12 Germany legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 13 Germany legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 14 UK legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 15 UK legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 16 Netherlands legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 17 Netherlands legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 18 Italy legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 19 Italy legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 20 Spain legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 21 Spain legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 22 Croatia legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 23 Croatia legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 24 Poland legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 25 Poland legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 26 Czech Republic legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 27 Czech Republic legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 28 Switzerland legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 29 Switzerland legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific legal marijuana market, by region, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 33 China legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 34 China legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 35 Japan legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 36 Japan legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 37 India legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 38 India legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 39 New Zealand legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 40 New Zealand legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 41 Australia legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 42 Australia legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 43 Thailand legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 44 Thailand legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 45 Latin America legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 46 Latin America legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 47 Latin America legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 48 Brazil legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 49 Brazil legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 50 Mexico legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 51 Mexico legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 52 Uruguay legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 53 Uruguay legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 54 Colombia legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 55 Colombia legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 56 MEA legal marijuana market, by region, 2018 - 2030 (USD Million)
  • Table 57 MEA legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 58 MEA legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 59 South Africa legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 60 South Africa legal marijuana market, by product type, 2018 - 2030 (USD Million)
  • Table 61 Israel legal marijuana market, by application, 2018 - 2030 (USD Million)
  • Table 62 Israel legal marijuana market, by product type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Legal marijuana market: market outlook
  • Fig. 9 Legal marijuana competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Legal marijuana market driver impact
  • Fig. 15 Legal marijuana market restraint impact
  • Fig. 16 Legal marijuana market strategic initiatives analysis
  • Fig. 17 Legal marijuana market: Application movement analysis
  • Fig. 18 Legal marijuana market: Application outlook and key takeaways
  • Fig. 19 Medical market estimates and forecast, 2018 - 2030
  • Fig. 20 Chronic Pain market estimates and forecast, 2018 - 2030
  • Fig. 21 Cryoablation market estimates and forecast, 2018 - 2030
  • Fig. 22 Cancer market estimates and forecast, 2018 - 2030
  • Fig. 23 Depression and Anxiety market estimates and forecast, 2018 - 2030
  • Fig. 24 Arthritis market estimates and forecast, 2018 - 2030
  • Fig. 25 Diabetes market estimates and forecast, 2018 - 2030
  • Fig. 26 Glaucoma market estimates and forecast, 2018 - 2030
  • Fig. 27 Migraines market estimates and forecast, 2018 - 2030
  • Fig. 28 Epilepsy market estimates and forecast, 2018 - 2030
  • Fig. 29 Multiple Sclerosis market estimates and forecast, 2018 - 2030
  • Fig. 30 AIDS market estimates and forecast, 2018 - 2030
  • Fig. 31 Amyotrophic Lateral Sclerosis market estimates and forecast, 2018 - 2030
  • Fig. 32 Post-traumatic Stress Disorder (PTSD) market estimates and forecast, 2018 - 2030
  • Fig. 33 Parkinson's market estimates and forecast, 2018 - 2030
  • Fig. 34 Tourette's market estimates and forecast, 2018 - 2030
  • Fig. 35 Others market estimates and forecast, 2018 - 2030
  • Fig. 36 Adult Use market estimates and forecast, 2018 - 2030
  • Fig. 37 Legal marijuana Market: Product Type movement Analysis
  • Fig. 38 Legal marijuana market: Product Type outlook and key takeaways
  • Fig. 39 Flower market estimates and forecasts, 2018 - 2030
  • Fig. 40 Oil and Tinctures market estimates and forecasts, 2018 - 2030
  • Fig. 41 Global Legal marijuana market: Regional movement analysis
  • Fig. 42 Global Legal marijuana market: Regional outlook and key takeaways
  • Fig. 43 Global Legal marijuana market share and leading players
  • Fig. 44 North America market share and leading players
  • Fig. 45 Europe market share and leading players
  • Fig. 46 Asia Pacific market share and leading players
  • Fig. 47 Latin America market share and leading players
  • Fig. 48 Middle East & Africa market share and leading players
  • Fig. 49 North America, by country
  • Fig. 50 North America
  • Fig. 51 North America market estimates and forecasts, 2018 - 2030
  • Fig. 52 U.S.
  • Fig. 53 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 54 Canada
  • Fig. 55 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 56 Europe
  • Fig. 57 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 58 UK
  • Fig. 59 UK market estimates and forecasts, 2018 - 2030
  • Fig. 60 Germany
  • Fig. 61 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 62 Netherlands
  • Fig. 63 Netherlands market estimates and forecasts, 2018 - 2030
  • Fig. 64 Italy
  • Fig. 65 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 66 Spain
  • Fig. 67 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 68 Croatia
  • Fig. 69 Croatia market estimates and forecasts, 2018 - 2030
  • Fig. 70 Poland
  • Fig. 71 Poland market estimates and forecasts, 2018 - 2030
  • Fig. 72 Czech Republic
  • Fig. 73 Czech Republic market estimates and forecasts, 2018 - 2030
  • Fig. 74 Switzerland
  • Fig. 75 Switzerland market estimates and forecasts, 2018 - 2030
  • Fig. 76 Asia Pacific
  • Fig. 77 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 78 China
  • Fig. 79 China market estimates and forecasts, 2018 - 2030
  • Fig. 80 Japan
  • Fig. 81 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 82 India
  • Fig. 83 India market estimates and forecasts, 2018 - 2030
  • Fig. 84 Thailand
  • Fig. 85 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 86 New Zealand
  • Fig. 87 New Zealand market estimates and forecasts, 2018 - 2030
  • Fig. 88 Australia
  • Fig. 89 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 90 Latin America
  • Fig. 91 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 92 Brazil
  • Fig. 93 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 94 Mexico
  • Fig. 95 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 96 Colombia
  • Fig. 97 Colombia market estimates and forecasts, 2018 - 2030
  • Fig. 98 Uruguay
  • Fig. 99 Uruguay market estimates and forecasts, 2018 - 2030
  • Fig. 100 Middle East and Africa
  • Fig. 101 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 102 South Africa
  • Fig. 103 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 104 Israel
  • Fig. 105 Israel Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 106 Market share of key market players- Legal marijuana market